Login / Signup

Effect of senna glycoside on serum potassium levels among patients on maintenance hemodialysis: A randomized controlled trial.

Naowanit NataWasin BunpethPamila TasanavipasNarittaya VarothaiOuppatham SupasyndhBancha Satirapoj
Published in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2021)
Among patients with ESRD on hemodialysis, senna glycoside significantly decreases serum potassium level. Senna glycoside is a safe and possibly effective alternative treatment for hyperkalemia in ESRD.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • peritoneal dialysis
  • combination therapy